Hepatitis B virus-induced liver injury and altered expression of carcinogen metabolising enzymes: The role of the HBx protein

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 595-601

  Chomarat, Pascale ^a   Rice, Jerry M ^a   Slagle, Betty L ^b   Wild, Christopher P ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cytochrome P450; GST; Liver cancer; X protein

Indexed keywords

AFLATOXIN; ALPHA 1 ANTITRYPSIN; BIOCHEMICAL MARKER; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; ENZYME ACTIVITY; GENE ACTIVATION; HEPATITIS B VIRUS; IMMUNOHISTOCHEMISTRY; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GLUTATHIONE TRANSFERASE; HEPATITIS B; LIVER; MALE; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; TRANS-ACTIVATORS;

ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 17444438044     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00254-9     Document Type: Conference Paper

References (19)

1. Allen, S.J., Wild, C.P., Wheeler, J.G., et al., 1992. Aflatoxin exposure malaria and hepatitis B infection in rural Gambian children. Trans. R. Soc. Trop. Med. Hyg. 86, 426-430.
2. Chemin, I., Takahashi, S., Belloc, C., et al., 1996. Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis. Hepatology 24, 649-656.
3. Chisari, F.V., Klopchin, K., Moriyama, T., et al., 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59, 1145-1156.
4. Chomarat, P., Sipowicz, M.A., Diwan, B.A., et al., 1997. Distinct time courses of increase in cytochromes P450 1A2, 2A5 and glutathione S-transferases during the progressive hepatitis associated with Helicobacter hepaticus. Carcinogenesis 18, 2179-2190.
5. Doria, M., Klein, N., Lucito, R., Schneider, R.J., 1995. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J. 14, 4747-4757.
6. Eaton, D.L., Gallagher, E.P., 1994. Mechanisms of aflatoxin carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 34, 135-172.
7. Feitelson, M.A., Duan, L.X., 1997. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am. J. Pathol. 150, 1141-1157.
8. Fukuda, Y., Ishida, N., Noguchi, T., Kappas, A., Sassa, S., 1992. Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells. Biochem. Biophys. Res. Commun. 184, 960-965.
9. Hagen, T.M., Huang, S., Curnutte, J., et al., 1994. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 91, 12808-12812.
10. 14C-caffeine breath test. Pharmacol. Toxicol. 77, 247-249.
11. Kim, C.M., Koike, K., Saito, I., Miyamura, T., Jay, G., 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317-320.
12. Kirby, G.M., Chemin, I., Montesano, R., Chisari, F.V., Lang, M.A., Wild, C.P., 1994a. Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol. Carcinog. 11, 74-80.
13. Kirby, G.M., Pelkonen, P., Vatanasapt, V., Camus, A.M., Wild, C.P., Lang, M.A., 1994b. Association of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver. Mol. Carcinog. 11, 81-89.
14. Langouet, S., Corcos, L., Abdel-Razzak, Z., Loyer, P., Ketterer, B., Guillouzo, A., 1995. Up-regulation of glutathione S-transferases alpha by interleukin 4 in human hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 216, 793-800.
15. Lee, T.H., Finegold, M.J., Shen, R.F., DeMayo, J.L., Woo, S.L.C., Butel, J.S., 1990. Hepatitis B virus transactivator X protein is not tumourigenic in transgenic mice. J. Virol. 64, 5939-5947.
16. Montesano, R., Hainaut, P., Wild, C.P., 1997. Hepatocellular Carcinoma: from gene to public health. J. Natl. Cancer Inst. 89, 1844-1851.
17. Slagle, B.L., Lee, T.H., Medina, D., Finegold, M.J., Butel, J.S., 1996. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog. 15, 261-269.
18. Wild, C.P., Jansen, L.A., Cova, L., Montesano, R., 1993a. Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ. Health Perspect. 99, 115-122.
19. Wild, C.P., Fortuin, M., Donato, F., et al., 1993b. Aflatoxin, liver enzymes and hepatitis B virus infection in Gambian children. Cancer Epidemiol. Biomarkers. Prev. 2, 1-7.